These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3791404)

  • 1. Papaverine: the ideal coronary vasodilator for investigating coronary flow reserve? A study of timing, magnitude, reproducibility, and safety of the coronary hyperemic response after intracoronary papaverine.
    Zijlstra F; Serruys PW; Hugenholtz PG
    Cathet Cardiovasc Diagn; 1986; 12(5):298-303. PubMed ID: 3791404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value and limitations of intracoronary adenosine for the assessment of coronary flow reserve.
    Zijlstra F; Juillière Y; Serruys PW; Roelandt JR
    Cathet Cardiovasc Diagn; 1988; 15(2):76-80. PubMed ID: 3180211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of intravenous adenosine to intracoronary papaverine for calculation of pressure-derived fractional flow reserve.
    van der Voort PH; van Hagen E; Hendrix G; van Gelder B; Bech JW; Pijls NH
    Cathet Cardiovasc Diagn; 1996 Oct; 39(2):120-5. PubMed ID: 8922309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracoronary and intravenous adenosine 5'-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans.
    De Bruyne B; Pijls NH; Barbato E; Bartunek J; Bech JW; Wijns W; Heyndrickx GR
    Circulation; 2003 Apr; 107(14):1877-83. PubMed ID: 12668522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of adenosine on human coronary arterial circulation.
    Wilson RF; Wyche K; Christensen BV; Zimmer S; Laxson DD
    Circulation; 1990 Nov; 82(5):1595-606. PubMed ID: 2225364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired coronary vasodilator reserve in the immediate postcoronary angioplasty period: analysis of coronary artery flow velocity indexes and regional cardiac venous efflux.
    Kern MJ; Deligonul U; Vandormael M; Labovitz A; Gudipati CV; Gabliani G; Bodet J; Shah Y; Kennedy HL
    J Am Coll Cardiol; 1989 Mar; 13(4):860-72. PubMed ID: 2522463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous adenosine: continuous infusion and low dose bolus administration for determination of coronary vasodilator reserve in patients with and without coronary artery disease.
    Kern MJ; Deligonul U; Tatineni S; Serota H; Aguirre F; Hilton TC
    J Am Coll Cardiol; 1991 Sep; 18(3):718-29. PubMed ID: 1869735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracoronary papaverine: an ideal coronary vasodilator for studies of the coronary circulation in conscious humans.
    Wilson RF; White CW
    Circulation; 1986 Mar; 73(3):444-51. PubMed ID: 3948354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracoronary papaverine induced myocardial lactate production in patients with angiographically normal coronary arteries.
    Takeuchi M; Nohtomi Y; Kuroiwa A
    Cathet Cardiovasc Diagn; 1996 Oct; 39(2):126-30. PubMed ID: 8922310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and safety of intracoronary papaverine, alprostadil, and high dosages of nicorandil and adenosine triphosphate for measurement of the index of coronary microcirculatory resistance in a pig model.
    Duan T; Zhang J; Xiang D; Song R; Kong R; Xu D
    Adv Clin Exp Med; 2019 Oct; 28(10):1409-1418. PubMed ID: 31638745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of ionic and nonionic radiographic contrast media on coronary hyperemia in patients during coronary angiography.
    Tatineni S; Kern MJ; Deligonul U; Aguirre F
    Am Heart J; 1992 Mar; 123(3):621-7. PubMed ID: 1539514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of phentolamine on the hyperemic response to adenosine in patients with microvascular disease.
    Aarnoudse W; Geven M; Barbato E; Botman KJ; De Bruyne B; Pijls NH
    Am J Cardiol; 2005 Dec; 96(12):1627-30. PubMed ID: 16360347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary hyperemic dose responses of intracoronary sodium nitroprusside.
    Parham WA; Bouhasin A; Ciaramita JP; Khoukaz S; Herrmann SC; Kern MJ
    Circulation; 2004 Mar; 109(10):1236-43. PubMed ID: 14993141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary microvascular response to intracoronary administration of nicorandil.
    Hongo M; Takenaka H; Uchikawa S; Nakatsuka T; Watanabe N; Sekiguchi M
    Am J Cardiol; 1995 Feb; 75(4):246-50. PubMed ID: 7832132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Measurement of coronary flow reserve using adenosine 5'-triphosphate in dogs].
    Kohno H; Yamada H; Azuma A; Kondo M; Yagi T; Kawata K; Tatsukawa H; Sugihara H; Nakagawa M
    J Cardiol; 1998 Jul; 32(1):1-8. PubMed ID: 9739511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary vasodilator reserve. Comparison of the effects of papaverine and adenosine on coronary flow, ventricular function, and myocardial metabolism.
    Christensen CW; Rosen LB; Gal RA; Haseeb M; Lassar TA; Port SC
    Circulation; 1991 Jan; 83(1):294-303. PubMed ID: 1984887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of Hyperemia With Intracoronary Administration of Papaverine.
    Mizukami T; Sonck J; Gallinoro E; Kodeboina M; Canvedra A; Nagumo S; Bartunek J; Wyffels E; Vanderheyden M; Shinke T; De Bruyne B; Collet C
    J Am Heart Assoc; 2021 Feb; 10(3):e018562. PubMed ID: 33459027
    [No Abstract]   [Full Text] [Related]  

  • 18. Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements.
    Jeremias A; Whitbourn RJ; Filardo SD; Fitzgerald PJ; Cohen DJ; Tuzcu EM; Anderson WD; Abizaid AA; Mintz GS; Yeung AC; Kern MJ; Yock PG
    Am Heart J; 2000 Oct; 140(4):651-7. PubMed ID: 11011341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial contrast echocardiography for assessment of papaverine vasodilator response in patients with angiographically normal coronary arteries and in patients after orthotopic heart transplantation.
    Klauss V; Mudra H; Sbarouni E; Meissner O; Metz J; Theisen K
    Z Kardiol; 1995 Oct; 84(10):852-9. PubMed ID: 7502573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is coronary flow reserve in response to papaverine really normal in syndrome X?
    Chauhan A; Mullins PA; Petch MC; Schofield PM
    Circulation; 1994 May; 89(5):1998-2004. PubMed ID: 8181123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.